Literature DB >> 10372712

Relative hyperproinsulinemia as a sign of islet dysfunction in women with impaired glucose tolerance.

H Larsson1, B Ahrén.   

Abstract

Proinsulin release is increased relative to insulin secretion in subjects with type 2 diabetes, indicative of islet dysfunction. However, it has not been conclusively shown whether there is an increased relative proinsulin release in subjects with impaired glucose tolerance (IGT), i.e. whether it precedes the development of diabetes. We therefore determined the proinsulin to insulin ratios in the fasting state and after acute stimulation of insulin secretion in 23 postmenopausal women, aged 61-62 yr (mean +/- SD, 61.7 +/- 0.5 yr). Ten women had normal glucose tolerance (NGT), and 13 had IGT. The groups were matched for insulin sensitivity and did not differ in body mass index. Proinsulin and insulin secretion were measured after arginine stimulation (5 g, i.v.) at three glucose levels (fasting, 14 mmol/L, and >25 mmol/L), and the acute insulin (AIR(arg)) and proinsulin responses (APIR(arg)) were calculated as the mean 2-5 min postload increase. At fasting glucose, levels of insulin, proinsulin, or the proinsulin/insulin ratio (13.6 +/- 5.0% vs. 11.1 +/- 2.7%; P = NS) did not differ between NGT and IGT. Although the AIR(arg) values were decreased in the IGT group at all glucose levels (P < 0.05), the absolute proinsulin levels and the APIRs(arg) were similar between IGT and NGT women. Therefore, the IGT women had higher proinsulin/insulin ratios at 14 mmol/L (10.7 +/- 4.4% vs. 6.4 +/- 1.8%; P = 0.006) and more than 25 mmol/L glucose (11.4 +/- 5.2% vs. 6.7 +/- 2.1%; P = 0.007). The IGT group had increased APIR(arg)/AIR(arg) at fasting (2.2 +/- 1.4% vs. 1.3 +/- 0.6%; P = 0.047) and more than 25 mmol/L glucose (3.5 +/- 1.6% vs. 2.3 +/- 0.7%; P = 0.037). We conclude that women with IGT exhibit increased relative proinsulin secretion, suggesting a defect in the intracellular proinsulin processing before diabetes develops.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10372712     DOI: 10.1210/jcem.84.6.5717

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  14 in total

1.  Proinsulin-to-C-peptide ratio versus proinsulin-to-insulin ratio in the prediction of incident diabetes: the Insulin Resistance Atherosclerosis Study (IRAS).

Authors:  R C Loopstra-Masters; S M Haffner; C Lorenzo; L E Wagenknecht; A J Hanley
Journal:  Diabetologia       Date:  2011-09-30       Impact factor: 10.122

2.  Non-alcoholic fatty liver disease and impaired proinsulin conversion as newly identified predictors of the long-term non-response to a lifestyle intervention for diabetes prevention: results from the TULIP study.

Authors:  Vera Schmid; Robert Wagner; Corinna Sailer; Louise Fritsche; Konstantinos Kantartzis; Andreas Peter; Martin Heni; Hans-Ulrich Häring; Norbert Stefan; Andreas Fritsche
Journal:  Diabetologia       Date:  2017-08-24       Impact factor: 10.122

3.  Exercise training and metformin, but not exercise training alone, decreases insulin production and increases insulin clearance in adults with prediabetes.

Authors:  Richard Viskochil; Steven K Malin; Jennifer M Blankenship; Barry Braun
Journal:  J Appl Physiol (1985)       Date:  2017-05-04

4.  Rapid deterioration of insulin secretion in obese adolescents preceding the onset of type 2 diabetes.

Authors:  Deborah A Elder; Lindsey N Hornung; Patricia M Herbers; Ron Prigeon; Jessica G Woo; David A D'Alessio
Journal:  J Pediatr       Date:  2014-12-31       Impact factor: 4.406

5.  In type 2 diabetes patients, insulin glargine is associated with lower postprandial release of intact proinsulin compared with sulfonylurea treatment.

Authors:  Stefan Pscherer; Martin Larbig; Berndt von Stritsky; Andreas Pfützner; Thomas Forst
Journal:  J Diabetes Sci Technol       Date:  2012-05-01

6.  Proinsulin associates with poor β-cell function, glucose-dependent insulinotropic peptide, and insulin resistance in persistent type 2 diabetes after Roux-en-Y gastric bypass in humans.

Authors:  Kapila Patel; Kiarra Levesque; Victoria Mark; Esmeralda Pierini; Betsy Rojas; Michael Ahlers; Ankit Shah; Blandine Laferrère
Journal:  J Diabetes       Date:  2019-07-24       Impact factor: 4.006

7.  Fasting proinsulin levels are significantly associated with 20 year cancer mortality rates. The Hoorn Study.

Authors:  I Walraven; E van 't Riet; C D A Stehouwer; B C P Polak; A C Moll; J M Dekker; G Nijpels
Journal:  Diabetologia       Date:  2013-03-05       Impact factor: 10.122

8.  Polymorphisms in the TCF7L2, CDKAL1 and SLC30A8 genes are associated with impaired proinsulin conversion.

Authors:  K Kirchhoff; F Machicao; A Haupt; S A Schäfer; O Tschritter; H Staiger; N Stefan; H-U Häring; A Fritsche
Journal:  Diabetologia       Date:  2008-02-09       Impact factor: 10.122

9.  Polymorphism rs11085226 in the gene encoding polypyrimidine tract-binding protein 1 negatively affects glucose-stimulated insulin secretion.

Authors:  Martin Heni; Caroline Ketterer; Robert Wagner; Katarzyna Linder; Anja Böhm; Silke A Herzberg-Schäfer; Fausto Machicao; Klaus-Peter Knoch; Andreas Fritsche; Harald Staiger; Hans-Ulrich Häring; Michele Solimena
Journal:  PLoS One       Date:  2012-10-15       Impact factor: 3.240

10.  DC260126: a small-molecule antagonist of GPR40 that protects against pancreatic β-Cells dysfunction in db/db mice.

Authors:  Peng Sun; Ting Wang; Yuren Zhou; Hong Liu; Hualiang Jiang; Weiliang Zhu; Heyao Wang
Journal:  PLoS One       Date:  2013-06-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.